This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Hetero Labs Limited, Dfh Therapeutics, Inc., Hetero Research Foundation. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 15 
1 out of 2 
1 out of 49 Years Active: 2017-2021
Title: Gazula Levi David Krupadanam: Innovator in HIV Research
Introduction
Gazula Levi David Krupadanam is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds aimed at treating viral diseases, including HIV. With a total of 3 patents to his name, Krupadanam's work is recognized for its potential impact on public health.
Latest Patents
Krupadanam's latest patents include the invention of C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors. This invention relates to C-3 novel triterpenone with C-17 reverse amide derivatives, related compounds, and pharmaceutical compositions that are useful for the therapeutic treatment of viral diseases, particularly those mediated by HIV. His innovative approach in this area showcases his commitment to advancing medical science and improving treatment options for patients.
Career Highlights
Throughout his career, Krupadanam has worked with prominent organizations such as Hetero Labs Limited and Hetero Research Foundation. His experience in these companies has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Bandi Parthasaradhi Reddy and Kura Rathnakar Reddy. Their collaborative efforts have further enhanced the research and development of effective treatments for viral diseases.
Conclusion
Gazula Levi David Krupadanam stands out as an influential inventor in the realm of HIV research. His innovative patents and collaborations reflect his dedication to improving healthcare outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile